生物阻抗技术在跨性别患者体成分评估中的应用案例
Body composition beyond the binary: bioimpedance as a case study for considering transgender patients in body composition technology development
生物阻抗技术(Bioimpedance)通过测量生物组织的电学特性来估算体成分,包括体细胞质量、脂肪-free 质量等。该技术在跨性别患者体成分评估中具有潜力,但传统单频生物阻抗(SF-BIA)方法存在个体准确性不足的问题。多频生物阻抗(MF-BIA)和分段生物阻抗技术可提高准确性,但仍需进一步验证。
Bioimpedance and BIA overview
Bioimpedance is the basis of techniques including Bioelectrical Impedance Analysis (BIA), Bioimpedance Spectroscopy (BIS), and Bioelectrical Impedance Vector Analysis (BIVA) [5]. The technique is non-invasive, painless, and uses electrodes to drive a small current through the body at one or more frequencies to measure the electrical properties of biological tissue. Bioimpedance can be used to estimate body composition by relating measured electrical tissue properties to body composition parameters such as total body water (TBW), body cell mass (BCM), and fat-free mass (FFM) [6, 7]. Bioimpedance measurement devices come in a variety of form factors, including instrumented weight scales (with or without a handle) and standalone devices that allow arbitrary electrode placement.
Bioimpedance-based techniques leverage two main principles: (1) an inverse relationship between the volume and resistance of a conductive cylinder (Fig. 1), and (2) the fact that said conductive cylinder can be modeled with distinct compartments, including Extracellular Water (ECW), Intracellular Water (ICW), and non-conductive material (fat, bone, etc.) (Fig. 2) [6]. Consider a single cylinder with uniform resistivity ρ, cross-sectional area A and length L (Fig. 1). If one measures the resistance of the cylinder (as done with bioimpedance), the volume can be calculated as:
$$R=\,\frac{\rho L}{A}\cdot \frac{L}{L}=\frac{\rho {L}^{2}}{{Vol}}$$
(1)
$${Vol}=\,\frac{\rho {L}^{2}}{R}$$
(2)
While L and A can be measured directly, ρ is unknown, and is a lumped resistivity as the body is made of compartments with different electrical properties (Fig. 2). If one assumes the volume Vol corresponds to TBW, which is typically approximated as 73% of fat-free mass (the remainder of which includes bone and protein) [6], Vol can be used to estimate fat-free mass by calculating the mass of the TBW using the density of TBW (0.994 g/ml) and dividing by 0.73. The fat mass (FM) and body fat percentage (BF%) can then be estimated using the FFM:
$${FFM}=\frac{{Vol}{\cdot D}_{{TBW}}}{0.73}$$
(3)
$${FM}={Weight}-{FFM}$$
(4)
$${BF} \% =\,\frac{{FM}}{{FM}+{FFM}}\cdot 100$$
(5)
The volume of a conductive cylinder with a resistivity ρ, cross-sectional area A and length L can be determined by measuring the resistance R of the cylinder if A and L are known (see Eqs. 1 and 2).
Body segments can be modeled as resistive cylinders with three compartments (Extracellular Water, Intracellular Water, and non-conducting material). At low frequencies, only the Extracellular Water is conductive; at high frequencies, both the Extracellular Water and Intracellular Water are conductive (i.e., Total Body Water).
BIA, the classical and most widely used bioimpedance-based approach to body composition [7, 8], does not attempt to estimate fat-free mass resistivity or density directly; instead, it uses linear regressions, typically with an L2/R term (Eq. 2), along with other terms that improve accuracy at the population level. Most of these equations are proprietary and depend on the bioimpedance hardware and electrode configuration. Here is an example of a publicly available equation from Kyle et al. [9]:
$$\begin{array}{c}{FFM}=\,-4.104+\left(0.518\,\cdot \frac{{H}^{2}}{R}\right)+\left(0.231\cdot {weight}\right)+\\ \left(0.130\cdot X\right)+\left(4.229\cdot {sex}\,:{men}=1,\,{women}=0\right)\end{array}$$
(6)
Here H is the height of the patient (i.e. the length L of the cylinder), R and X are the resistance and reactance (the real and imaginary components of the bioimpedance), and sex is either 1 or 0 depending on (presumably) the sex assigned at birth of the patient (this study, and many others even in more recent years, do not define the term “sex” or describe how it was collected [4]). Sex is included to reflect the sexual dimorphism of body composition [2] and is included to improve population-level accuracy; in this case, the variable sex acts as a binary offset depending on the recorded sex of the patient in the study. These equations typically use another method, such as DXA or MRI, as a reference method. Other parameters, such as skeletal muscle, cell mass, etc., can also be estimated using similar assumptions and dedicated equations [6].
Improvements and alternatives to classical BIA
BIA’s accuracy in clinical practice can be limited as the linear regression technique reduces the mean error across the population, and thus it can be inaccurate at the individual level [8]. There are several approaches that have been explored to improve the accuracy of bioimpedance-based body composition techniques compared with BIA. One possibility is measuring bioimpedance at multiple frequencies. Equation 6 uses single-frequency bioimpedance (SF-BIA). Electrical tissue properties depend on frequency, so SF-BIA typically uses current at 50 kHz, a frequency in the middle of the relevant range for human tissue. However, this means that current flows through only a fraction of the TBW, and that fraction will differ from patient to patient, which can contribute to another source of error. While performing BIA at multiple frequencies (i.e., MF-BIA) increases available information, neither SF-BIA nor MF-BIA relies on regression equations to estimate ECW or TBW [6]. Other approaches include measuring bioimpedance at multiple segments (segmental SF-BIA/MF-BIA) [10] and using mixture theory to minimize dependence on linear regressions (Bioimpedance Spectroscopy, abbreviated as BIS) [11].
Segmental BIA measures the bioimpedance of multiple body segments and assumes that those individual body segments have some similar unknown resistivity. This can reduce error because the body is not a single cylinder. While some initial studies measured the length and cross-sectional area of body segments directly, allowing estimation of limb volume [10], the geometry of these individual segments is not typically measured directly, as that would be cumbersome for the patient and/or operator. Instead, a “shape factor” KB is used, a unitless ratio that aims to capture the relative contributions of the arms, legs, and trunk to the measurement [12]. While a standard KB value was proposed in [12], the shape factor can vary considerably based on patient height and weight [13], reducing some of the theoretical benefits of the segmental approach.
Where different variations on BIA (SF/MF-BIA, segmental SF/MF-BIA) address the aforementioned assumptions using a linear regression, Bioimpedance Spectroscopy (BIS) approximates the resistance at low and high frequencies (\({R}_{0}\) and \({R}_{\infty }\)) by measuring bioimpedance across a wide frequency range and uses mixture theory to estimate ECW and TBW volume more directly, which can then be related to other estimates of body composition [6, 11]. Rather than assuming a lumped unknown resistivity, mixture theory models tissue at low frequencies as a series of nonconductive spheres (cells) inside a conductive fluid (ECW) [14]. The resistivity \(\rho\) is then a function of the resistivity of the conductive fluid \({\rho }_{{ECW}}\) and the volume fraction c:
$$\rho =\,\frac{{\rho }_{{ECW}}}{{(1-c)}^{3/2}}$$
(7)
Combining Eq. 7 with Eq. 2, the volume of the ECW \({{Vol}}_{{ECW}}\) of a cylindrical body segment would become [15]:
$${{Vol}}_{{ECW}}={\left(\frac{{L}^{2}{\rho }_{{ECW}}\sqrt{{LA}}}{{R}_{0}}\right)}^{2/3}$$
(8)
A similar approach can be taken to estimate the TBW of a cylindrical segment [16]:
$${{Vol}}_{{TBW}}={\left(\frac{{L}^{2}{\rho }_{\infty }\sqrt{{LA}}}{{R}_{\infty }}\right)}^{2/3}$$
(9)
$${\rho }_{\infty }={\rho }_{{ICW}}-\left({\rho }_{{ICW}}-{\rho }_{{ECW}}\right){\left(\frac{{R}_{\infty }}{{R}_{0}}\right)}^{\frac{2}{3}}$$
(10)
\({{Vol}}_{{TBW}}\) can then be used to estimate body composition using the approach in Eqs. 3–5. When estimating ECW/TBW of the entire body and not a segment, volume estimates from multiple segments can be combined, or the shape factor KB can be used in lieu of measuring segment geometry directly.
Implications for transgender patients
Bioimpedance-based estimates of in vivo body composition must make assumptions, as current only flows through a fraction of the fat-free mass, thus necessitating the use of a two-compartment model (fat vs. fat-free mass) rather than a four-compartment model that separates out the three components of fat-free mass (water, protein, and minerals) [17]. Some of the other assumptions made may be able to be mitigated.
Despite their limitations, BIA-based approaches are the most widely available bioimpedance-based techniques due to their relative affordability. However, because BIA-based approaches rely on proprietary linear regressions, they can only be presumed accurate within the population used to generate the equations, and studies that are not explicitly about healthcare for transgender patients rarely report whether transgender participants were included in research studies [4]. Clinicians and researchers, therefore, typically must conduct validation studies comparing the accuracy of BIA against reference methods such as DXA or MRI before using the technology with their transgender patients, who may have a wide range of body compositions and varied use of gender-affirming care. In practice, few studies involving transgender patients use BIA (let alone any other bioimpedance-based approach like BIS), instead relying on DXA or MRI, which are less readily available and much more expensive [3].
Even if BIS were used more widely, most implementations still use a shape factor term, which can vary with sex [13] and change as body composition changes. One exciting possibility for future work is to leverage digital anthropometry techniques to directly estimate shape factor [18]. More accurate bioimpedance-based technologies could improve the study of body composition not only for transgender patients but for everyone.
来源:Nature 健康护理主题 · nature.com